Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sensei Biotherapeutics, Inc.

0.3800
-0.0057-1.48%
Post-market: 0.3779-0.0021-0.55%17:12 EDT
Volume:59.08K
Turnover:22.97K
Market Cap:9.58M
PE:-0.32
High:0.4000
Open:0.4000
Low:0.3766
Close:0.3857
Loading ...
Jun 02, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 23, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
May 01, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 20, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 07, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Major Issues Report

8-K - Current report
Dec 09, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Major Issues Report

8-K - Current report
Nov 21, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2022

Major Issues Report

8-K - Current report